Skip to content

Clinical trials

Phase 2 Neoplasm Metastasis trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2 Country / region: Belgium Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20034
20052
20062
20075
20082
20096
20102
20113
20121
20135
20144
20152
20163
20173
20183
20196
20205
20214
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Terminated10
Active, not recruiting8
Unknown status4
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cliniques universitaires Saint-Luc- Université Catholique de Louvain4
Amgen3
AstraZeneca3
Bayer3
Merck KGaA, Darmstadt, Germany3
Novartis Pharmaceuticals3
University Hospital, Ghent3
Astellas Pharma Inc2
Daiichi Sankyo2
ETOP IBCSG Partners Foundation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis67
Breast Neoplasms18
Neoplasms13
Colorectal Neoplasms8
Recurrence8
Carcinoma, Non-Small-Cell Lung7
Prostatic Neoplasms6
Carcinoma, Transitional Cell3
Colonic Neoplasms3
Lung Neoplasms3

Trials

Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.